Nayef Alzahrani
Papers
1
Total Citations
2
H-Index
1
About
Dr. Nayef Alzahrani is a pioneering surgical oncologist whose work centers on the aggressive multimodal treatment of peritoneal metastasis (PM), a common and often fatal progression of abdominal cancers. His major contributions lie in advancing minimally invasive approaches—specifically robotic and laparoscopic cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC). As lead author of a landmark 2024 multicenter study from Saudi Arabia, Dr. Alzahrani demonstrated the feasibility and safety of these techniques in a national cohort, challenging traditional open-surgery paradigms and expanding access to life-extending therapy. His research, which has garnered early citations reflecting its clinical significance, provides critical evidence that robotic and laparoscopic CRS/HIPEC can achieve effective cytoreduction with reduced morbidity. By spearheading this collaborative effort across Saudi institutions, Dr. Alzahrani has not only advanced surgical oncology in the Middle East but also contributed to the global dialogue on optimizing care for patients with peritoneal surface malignancies. His work underscores a commitment to innovation, patient-centered outcomes, and the rigorous evaluation of emerging technologies in complex cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1